Physician profile

David S Marks

Interventional Cardiology · Milwaukee, WI

NPI 1164460010

$10,343.70

in general payments reported to CMS, 2019-2025

6 companies · $2,924 in 2025

The $2,924 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$6,970.00
Food and Beverage$58.70

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $10,285.00 2019-2025 Amplatzer Amulet, Jeti All In One Non-Sterile Kit
Heartflow, INC. $24.27 2024
Regeneron Healthcare Solutions, INC. $18.73 2025 Dupixent
Teleflex LLC $15.70 2025 Manta

2 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David S Marks

$10,343.70

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $2,924 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/143509/david-s-marks

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.